000739 普洛药业
已收盘 11-16 15:00:00
资讯
新帖
简况
普洛药业(000739)11月11日主力资金净卖出791.32万元
证券之星 · 11-12
普洛药业(000739)11月11日主力资金净卖出791.32万元
普洛药业(000739)11月3日主力资金净买入152.13万元
证券之星 · 11-04
普洛药业(000739)11月3日主力资金净买入152.13万元
股市必读:普洛药业新发布《关于回购公司股份的进展公告》
证券之星 · 11-04
股市必读:普洛药业新发布《关于回购公司股份的进展公告》
股市必读:普洛药业新发布《关于回购公司股份的进展公告》
证券之星 · 11-03
股市必读:普洛药业新发布《关于回购公司股份的进展公告》
普洛药业(000739)披露对下属公司担保进展公告,10月30日股价下跌0.67%
证券之星 · 10-30
普洛药业(000739)披露对下属公司担保进展公告,10月30日股价下跌0.67%
山西证券:给予普洛药业买入评级
证券之星 · 10-26
山西证券:给予普洛药业买入评级
股市必读:普洛药业(000739)10月23日收盘跌5.75%,主力净流出2940.14万元
证券之星 · 10-26
股市必读:普洛药业(000739)10月23日收盘跌5.75%,主力净流出2940.14万元
普洛药业(000739)2026年三季报简析:净利润同比下降12.37%
证券之星 · 10-24
普洛药业(000739)2026年三季报简析:净利润同比下降12.37%
10月23日普洛药业跌5.75%,大成睿享混合A基金重仓该股
证券之星 · 10-23
10月23日普洛药业跌5.75%,大成睿享混合A基金重仓该股
普洛药业(000739)披露2026年三季度报告,10月22日股价下跌1.42%
证券之星 · 10-22
普洛药业(000739)披露2026年三季度报告,10月22日股价下跌1.42%
普洛药业(000739.SZ)发布前三季度业绩,归母净利润6.14亿元,同比下降12.37%
智通财经 · 10-22
普洛药业(000739.SZ)发布前三季度业绩,归母净利润6.14亿元,同比下降12.37%
普洛药业(000739)10月21日主力资金净卖出879.67万元
证券之星 · 10-22
普洛药业(000739)10月21日主力资金净卖出879.67万元
10月19日普洛药业跌7.69%,大成睿享混合A基金重仓该股
证券之星 · 10-19
10月19日普洛药业跌7.69%,大成睿享混合A基金重仓该股
普洛药业(000739)10月9日主力资金净买入321.76万元
证券之星 · 10-12
普洛药业(000739)10月9日主力资金净买入321.76万元
10月9日普洛药业跌6.82%,大成睿享混合A基金重仓该股
证券之星 · 10-09
10月9日普洛药业跌6.82%,大成睿享混合A基金重仓该股
异动快报:普洛药业(000739)10月9日11点10分触及跌停板
证券之星 · 10-09
异动快报:普洛药业(000739)10月9日11点10分触及跌停板
股市必读:普洛药业新发布《关于对下属公司担保的进展公告》
证券之星 · 10-09
股市必读:普洛药业新发布《关于对下属公司担保的进展公告》
普洛药业(000739.SZ):氘恩扎鲁胺原料药获得化学原料药上市申请批准
智通财经网 · 10-08
普洛药业(000739.SZ):氘恩扎鲁胺原料药获得化学原料药上市申请批准
普洛药业涨5.97%,开源证券一个月前给出“买入”评级
证券之星 · 09-28
普洛药业涨5.97%,开源证券一个月前给出“买入”评级
股市必读:普洛药业新发布《2026年中期分红派息实施公告》
证券之星 · 09-28
股市必读:普洛药业新发布《2026年中期分红派息实施公告》
加载更多
公司概况
公司名称:
普洛药业股份有限公司
所属行业:
医药制造业
上市日期:
1997-05-09
主营业务:
普洛药业股份有限公司的主营业务是创新药研发生产服务(CDMO)、原料药中间体、药品等研发、生产和销售以及进出口贸易业务。公司的主要产品是原料药中间体、创新药研发生产服务、药品。
发行价格:
5.70
{"stockData":{"symbol":"000739","market":"SZ","secType":"STK","nameCN":"普洛药业","latestPrice":19.88,"timestamp":1794812613000,"preClose":19.51,"halted":0,"volume":11250102,"delay":0,"changeRate":0.019,"floatShares":1158000000,"shares":1158000000,"eps":0.6942,"marketStatus":"已收盘","change":0.37,"latestTime":"11-16 15:00:00","open":19.39,"high":20.32,"low":18.99,"amount":222000000,"amplitude":0.0682,"askPrice":19.89,"askSize":64,"bidPrice":19.88,"bidSize":200,"shortable":0,"etf":0,"ttmEps":0.6942,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794879000000},"marketStatusCode":5,"adr":0,"adjPreClose":19.51,"symbolType":"stock","openAndCloseTimeList":[[1794792600000,1794799800000],[1794805200000,1794812400000]],"highLimit":21.46,"lowLimit":17.56,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1158443576,"isCdr":false,"pbRate":3.53,"roa":"--","peRate":28.63728,"roe":"9.63%","epsLYR":0.7723,"committee":0.56,"marketValue":23030000000,"turnoverRate":0.0097,"status":0,"floatMarketCap":23021000000},"requestUrl":"/m/hq/s/000739","defaultTab":"news","newsList":[{"id":"2682653926","title":"普洛药业(000739)11月11日主力资金净卖出791.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682653926","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682653926?lang=zh_cn&edition=full","pubTime":"2026-11-12 09:18","pubTimestamp":1794446318,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月11日收盘,普洛药业报收于20.32元,下跌1.79%,换手率0.82%,成交量9.52万手,成交额1.95亿元。近5日资金流向一览见下表:普洛药业融资融券信息显示,融资方面,当日融资买入1523.6万元,融资偿还1394.93万元,融资净买入128.67万元。普洛药业主营业务:创新药研发生产服务、原料药中间体、药品等研发、生产和销售以及进出口贸易业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111200007517.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","LU1064130708.USD","BK0239","BK0188","LU2148510915.USD","000739","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680702959","title":"普洛药业(000739)11月3日主力资金净买入152.13万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680702959","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680702959?lang=zh_cn&edition=full","pubTime":"2026-11-04 09:42","pubTimestamp":1793756579,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月3日收盘,普洛药业报收于20.54元,上涨2.19%,换手率1.35%,成交量15.66万手,成交额3.19亿元。近5日资金流向一览见下表:普洛药业融资融券信息显示,融资方面,当日融资买入1108.19万元,融资偿还1777.77万元,融资净偿还669.59万元。普洛药业主营业务:创新药研发生产服务、原料药中间体、药品等研发、生产和销售以及进出口贸易业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400012265.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000739","BK0239","LU1064130708.USD","LU1064131003.USD","BK0060","LU2148510915.USD","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680034771","title":"股市必读:普洛药业新发布《关于回购公司股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680034771","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680034771?lang=zh_cn&edition=full","pubTime":"2026-11-04 04:03","pubTimestamp":1793736211,"startTime":"0","endTime":"0","summary":"公司公告汇总:截至2026年10月31日,普洛药业已回购股份5,720,100股,占总股本0.49%,累计支付回购金额105,910,596.95元,进展符合方案规定。公司公告汇总关于回购公司股份的进展公告普洛药业股份有限公司于2026年6月11日召开董事会、6月29日召开临时股东会,审议通过回购股份用于注销并减少注册资本的议案,回购资金总额不低于1亿元且不超过1.5亿元,回购价格上限为20元/股;因中期分红实施,回购价格上限调整为19.87元/股,自2026年10月8日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400006258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2148510915.USD","000739","LU1064130708.USD","BK0060","BK0239","BK0188","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680764787","title":"股市必读:普洛药业新发布《关于回购公司股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680764787","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680764787?lang=zh_cn&edition=full","pubTime":"2026-11-03 01:49","pubTimestamp":1793641789,"startTime":"0","endTime":"0","summary":"截至2026年11月2日收盘,普洛药业报收于20.1元,上涨3.77%,换手率1.52%,成交量17.56万手,成交额3.48亿元。公司公告汇总:截至10月31日,普洛药业已回购股份5,720,100股,占总股本0.49%,成交总金额105,910,596.95元,回购进展符合方案规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300003477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2148510915.USD","BK0060","LU1064130708.USD","BK0188","000739","LU1064131003.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679324341","title":"普洛药业(000739)披露对下属公司担保进展公告,10月30日股价下跌0.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679324341","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679324341?lang=zh_cn&edition=full","pubTime":"2026-10-30 22:59","pubTimestamp":1793372361,"startTime":"0","endTime":"0","summary":"截至2026年10月30日收盘,普洛药业报收于19.37元,较前一交易日下跌0.67%,最新总市值为224.39亿元。近日,普洛药业披露《关于对下属公司担保的进展公告》。其中为家园药业担保7,500万元,为得邦制药担保101万元,担保期限分别为1年、9个月和12个月。上述担保事项已履行董事会及股东会审议程序,属于公司对下属子公司的担保,截至公告日公司对下属公司担保余额为377,530.75万元,占2025年度经审计净资产的59.56%,无逾期担保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000058167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000739","LU2148510915.USD","BK0188","LU1064131003.USD","BK0060","BK0239","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678156355","title":"山西证券:给予普洛药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2678156355","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678156355?lang=zh_cn&edition=full","pubTime":"2026-10-26 12:14","pubTimestamp":1792988063,"startTime":"0","endTime":"0","summary":"山西证券股份有限公司邓周宇,魏赟,张智勇近期对普洛药业进行研究并发布了研究报告《CDMO布局已现成效,小分子/ADC/多肽驱动CDMO加速兑现》,给予普洛药业买入评级。持续覆盖,给予\"买入-B\"评级。最新盈利预测明细如下:该股最近90天内共有10家机构给出评级,买入评级10家;过去90天内机构目标均价为27.6。本文数据来源于山西证券股份有限公司,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600013006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000739","002500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678135792","title":"股市必读:普洛药业(000739)10月23日收盘跌5.75%,主力净流出2940.14万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678135792","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678135792?lang=zh_cn&edition=full","pubTime":"2026-10-26 01:27","pubTimestamp":1792949228,"startTime":"0","endTime":"0","summary":"截至2026年10月23日收盘,普洛药业报收于19.68元,下跌5.75%,换手率3.06%,成交量35.4万手,成交额6.78亿元。当日关注点交易信息汇总:普洛药业10月23日收盘跌5.75%至19.68元,主力资金单日净流出2940.14万元。交易信息汇总股价提醒10月23日普洛药业收盘报19.68元,跌5.75%,当日成交6.78亿元;前10个交易日主力资金累计净流出1.28亿元,融资余额减少117.75万元,融券余量减少8.22万股;近90天内10家机构均予“买入”评级,目标均价27.6元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600000446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","LU1064130708.USD","LU1064131003.USD","BK0239","LU2148510915.USD","BK0060","000739"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677787970","title":"普洛药业(000739)2026年三季报简析:净利润同比下降12.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677787970","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677787970?lang=zh_cn&edition=full","pubTime":"2026-10-24 06:04","pubTimestamp":1792793064,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期普洛药业发布2026年三季报。根据财报显示,普洛药业净利润同比下降12.37%。截至本报告期末,公司营业总收入68.35亿元,同比下降11.97%,归母净利润6.14亿元,同比下降12.37%。按单季度数据看,第三季度营业总收入20.11亿元,同比下降13.28%,第三季度归母净利润9129.34万元,同比下降33.47%。本文数据来源于普洛药业2026年三季报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102400005100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000739"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677594447","title":"10月23日普洛药业跌5.75%,大成睿享混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677594447","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677594447?lang=zh_cn&edition=full","pubTime":"2026-10-23 16:44","pubTimestamp":1792745058,"startTime":"0","endTime":"0","summary":"证券之星消息,10月23日普洛药业跌5.75%创60日新低,收盘报19.68元,换手率3.06%,成交量35.4万手,成交额6.78亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共20家,其中持有数量最多的公募基金为大成基金的大成睿享混合A。大成睿享混合A目前规模为32.15亿元,最新净值1.7231,较上一交易日下跌0.82%,近一年下跌2.16%。大成睿享混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300030453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","LU1064130708.USD","LU1064131003.USD","BK0239","LU2148510915.USD","BK0060","000739"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677961183","title":"普洛药业(000739)披露2026年三季度报告,10月22日股价下跌1.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677961183","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677961183?lang=zh_cn&edition=full","pubTime":"2026-10-22 22:20","pubTimestamp":1792678830,"startTime":"0","endTime":"0","summary":"截至2026年10月22日收盘,普洛药业报收于20.88元,较前一交易日下跌1.42%,最新总市值为241.88亿元。近日,普洛药业披露2026年三季度报告。公告显示,本报告期营业收入2,011,334,085.68元,同比下降13.28%;归属于上市公司股东的净利润91,293,384.59元,同比下降33.47%。年初至报告期末营业收入6,834,641,343.47元,同比下降11.97%;归属于上市公司股东的净利润613,668,047.11元,同比下降12.37%。经营活动产生的现金流量净额674,920,741.28元,同比下降12.80%。基本每股收益0.5309元,同比下降12.44%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200042774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000739","LU1064130708.USD","BK0188","LU2148510915.USD","LU1064131003.USD","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677930662","title":"普洛药业(000739.SZ)发布前三季度业绩,归母净利润6.14亿元,同比下降12.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677930662","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677930662?lang=zh_cn&edition=full","pubTime":"2026-10-22 16:20","pubTimestamp":1792657219,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普洛药业(000739.SZ)发布2026年第三季度报告,公司前三季度实现营业收入68.35亿元,同比下降11.97%;归属于上市公司股东的净利润6.14亿元,同比下降12.37%;归属于上市公司股东的扣除非经常性损益的净利润5.68亿元,同比下降12.22%;基本每股收益0.5309元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1510713.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000739"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677340981","title":"普洛药业(000739)10月21日主力资金净卖出879.67万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677340981","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677340981?lang=zh_cn&edition=full","pubTime":"2026-10-22 09:18","pubTimestamp":1792631915,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月21日收盘,普洛药业报收于21.18元,下跌2.49%,换手率0.94%,成交量10.87万手,成交额2.33亿元。近5日资金流向一览见下表:普洛药业融资融券信息显示,融资方面,当日融资买入889.29万元,融资偿还1221.73万元,融资净偿还332.43万元。普洛药业主营业务:创新药研发生产服务、原料药中间体、药品等研发、生产和销售以及进出口贸易业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200008218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2148510915.USD","BK0188","LU1064130708.USD","BK0060","LU1064131003.USD","BK0239","000739"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676509603","title":"10月19日普洛药业跌7.69%,大成睿享混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2676509603","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676509603?lang=zh_cn&edition=full","pubTime":"2026-10-19 16:32","pubTimestamp":1792398774,"startTime":"0","endTime":"0","summary":"证券之星消息,10月19日普洛药业跌7.69%,收盘报21.62元,换手率3.09%,成交量35.8万手,成交额7.75亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共20家,其中持有数量最多的公募基金为大成基金的大成睿享混合A。大成睿享混合A目前规模为32.15亿元,最新净值1.7532,较上一交易日下跌0.09%,近一年下跌1.26%。大成睿享混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900020438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000739","BK0239","LU1064131003.USD","LU1064130708.USD","BK0188","LU2148510915.USD","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674084752","title":"普洛药业(000739)10月9日主力资金净买入321.76万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674084752","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674084752?lang=zh_cn&edition=full","pubTime":"2026-10-12 09:12","pubTimestamp":1791767555,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月9日收盘,普洛药业报收于25.4元,下跌6.82%,换手率3.19%,成交量36.9万手,成交额9.37亿元。近5日资金流向一览见下表:普洛药业融资融券信息显示,融资方面,当日融资买入6831.05万元,融资偿还4401.51万元,融资净买入2429.55万元。融券方面,融券卖出3300.0股,融券偿还3000.0股,融券余量42.54万股,融券余额1080.52万元。普洛药业主营业务:创新药研发生产服务、原料药中间体、药品等研发、生产和销售以及进出口贸易业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200003017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064130708.USD","000739","LU1064131003.USD","LU2148510915.USD","BK0188","BK0060","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674583262","title":"10月9日普洛药业跌6.82%,大成睿享混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674583262","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674583262?lang=zh_cn&edition=full","pubTime":"2026-10-09 16:38","pubTimestamp":1791535132,"startTime":"0","endTime":"0","summary":"证券之星消息,10月9日普洛药业跌6.82%,收盘报25.4元,换手率3.19%,成交量36.9万手,成交额9.37亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共20家,其中持有数量最多的公募基金为大成基金的大成睿享混合A。大成睿享混合A目前规模为32.15亿元,最新净值1.7845,较上一交易日下跌0.82%,近一年上涨0.65%。大成睿享混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900025700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064131003.USD","000739","BK0188","LU2148510915.USD","BK0239","BK0060","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674887946","title":"异动快报:普洛药业(000739)10月9日11点10分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2674887946","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674887946?lang=zh_cn&edition=full","pubTime":"2026-10-09 11:15","pubTimestamp":1791515727,"startTime":"0","endTime":"0","summary":"证券之星10月9日盘中消息,11点10分普洛药业(000739)触及跌停板。其所属行业化学制药目前下跌。领涨股为向日葵。该股为化学原料药,流感,阿尔茨海默病概念热股。10月8日的资金流向数据方面,主力资金净流入113.45万元,占总成交额0.19%,游资资金净流入765.95万元,占总成交额1.27%,散户资金净流出879.4万元,占总成交额1.46%。近5日资金流向一览见下表:普洛药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900013869.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","LU1064130708.USD","LU2148510915.USD","BK0239","BK0188","000739","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674020280","title":"股市必读:普洛药业新发布《关于对下属公司担保的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674020280","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674020280?lang=zh_cn&edition=full","pubTime":"2026-10-09 03:18","pubTimestamp":1791487090,"startTime":"0","endTime":"0","summary":"截至公告日,公司对下属子公司担保余额为379,329.75万元,占公司2025年度经审计净资产的59.85%,无逾期担保。本次原料药获批将对公司CDMO业务及经营产生积极影响,并保障原料药供应。本次回购符合相关法规及公司方案规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900002867.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","LU1064130708.USD","BK0060","LU2148510915.USD","LU1064131003.USD","BK0239","000739"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673607672","title":"普洛药业(000739.SZ):氘恩扎鲁胺原料药获得化学原料药上市申请批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2673607672","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673607672?lang=zh_cn&edition=full","pubTime":"2026-10-08 18:45","pubTimestamp":1791456308,"startTime":"0","endTime":"0","summary":"普洛药业(000739.SZ)发布公告,近日,公司全资子公司浙江普洛家园药业有限公司收到国家药品监督管理局签发的氘恩扎鲁胺原料药《化学原料药上市申请批准通知书》。海纳安®(氘恩扎鲁胺软胶囊)是海创药业股份有限公司基于其氘代药物研发平台开发的一种新型雄激素受体(AR)抑制剂。该药于2025年5月获得国家药品监督管理局批准上市,后被2025版《CSCO前列腺癌诊疗指南》纳入mCRPC \n的全线推荐治疗方案,并于2025年12月纳入国家医保药品目录。","market":"us","thumbnail":"https://img.zhitongcaijing.com/astockgonggao/agugonggao7.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astockgonggao/agugonggao7.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504766.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU2148510915.USD","BK0239","IPOS","BK0060","000739","LU1064131003.USD","LU1064130708.USD","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670238801","title":"普洛药业涨5.97%,开源证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2670238801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670238801?lang=zh_cn&edition=full","pubTime":"2026-09-28 16:49","pubTimestamp":1790585343,"startTime":"0","endTime":"0","summary":"今日普洛药业涨5.97%,收盘报26.81元。2026年8月21日,开源证券研究员余汝意,阮帅发布了对普洛药业的研报《公司信息更新报告:CDMO业绩较快增长,盈利能力持续提高》,该研报对普洛药业给出“买入”评级。研报中预计2026-2028年归母净利润为10.25/12.43/15.21亿元,当前股价对应PE为23.4/19.3/15.8倍,估值性价比高,考虑公司CDMO业务较快增长且在手订单规模较大,维持“买入”评级。普洛药业个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800021646.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","000739"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670409692","title":"股市必读:普洛药业新发布《2026年中期分红派息实施公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2670409692","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670409692?lang=zh_cn&edition=full","pubTime":"2026-09-28 01:34","pubTimestamp":1790530449,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘,普洛药业报收于25.3元,下跌0.08%,换手率1.36%,成交量15.77万手,成交额4.0亿元。公司公告汇总:普洛药业发布2026年中期分红派息实施公告,以1,123,731,176股为基数,每10股派发现金红利1.39元(含税),合计派发156,198,633.46元(含税);股权登记日为2026年9月30日,除权除息日为2026年10月8日。公司回购专用账户股份不参与本次分配。本次权益分派后,公司回购价格上限及股权激励相关价格将作相应调整。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800000896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0060","000739"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794816519519,"stockEarnings":[{"period":"1week","weight":-0.0917},{"period":"1month","weight":-0.2066},{"period":"3month","weight":-0.1306},{"period":"6month","weight":0.1811},{"period":"1year","weight":0.2741},{"period":"ytd","weight":0.2201}],"compareEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":-0.0353},{"period":"3month","weight":-0.0746},{"period":"6month","weight":-0.1212},{"period":"1year","weight":-0.0981},{"period":"ytd","weight":-0.0843}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"普洛药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"37342人(较上一季度增加1.49%)","perCapita":"31010股","listingDate":"1997-05-09","address":"浙江省金华市东阳市横店江南路399号","registeredCapital":"115844万元","survey":" 普洛药业股份有限公司的主营业务是创新药研发生产服务(CDMO)、原料药中间体、药品等研发、生产和销售以及进出口贸易业务。公司的主要产品是原料药中间体、创新药研发生产服务、药品。","listedPrice":5.7},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"普洛药业(000739)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供普洛药业(000739)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"普洛药业,000739,普洛药业股票,普洛药业股票老虎,普洛药业股票老虎国际,普洛药业行情,普洛药业股票行情,普洛药业股价,普洛药业股市,普洛药业股票价格,普洛药业股票交易,普洛药业股票购买,普洛药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"普洛药业(000739)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供普洛药业(000739)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}